During epithelial infections, pathogenic bacteria employ an array of strategies to attenuate and evade host immune responses, including the influx of polymorphonuclear leukocytes (PMN; neutrophils). Among the most common bacterial infections in humans are those of the urinary tract, caused chiefly by uropathogenic Escherichia coli (UPEC). During the establishment of bacterial cystitis, UPEC suppresses innate responses via multiple independent strategies. We recently described UPEC attenuation of PMN trafficking to the urinary bladder through pathogen-specific local induction of indoleamine 2,3-dioxygenase (IDO), a tryptophan catabolic enzyme previously shown to have regulatory activity only in adaptive immunity. Here, we investigated the mechanism by which IDO induction attenuates PMN migration. Local tryptophan limitation, by which IDO is known to influence T cell longevity and proliferation, was not involved in its effect on PMN trafficking. Instead, metabolites in the IDO pathway, particularly L-kynurenine, directly suppressed PMN transepithelial migration and induced an attached, spread morphology in PMN both at rest and in the presence of chemotactic stimuli. Finally, kynurenines represent known ligands of the mammalian aryl hydrocarbon receptor (AHR), and UPEC infection of Ahr ؊/؊ mice recapitulated the derepressed PMN recruitment observed previously in Ido1 ؊/؊ mice. UPEC therefore suppresses neutrophil migration early in bacterial cystitis by eliciting an IDO-mediated increase in local production of kynurenines, which act through the AHR to impair neutrophil chemotaxis.
Indoleamine 2,3-dioxygenase (IDO) is a conserved mammalian metabolic enzyme that catalyzes the first step in tryptophan degradation along the kynurenine pathway. In addition to this role in nutrient utilization, IDO has been implicated in a number of biological processes related to regulation of local immunity such as fetal tolerance, autoimmunity, organ transplantation, and tumorigenesis (1). The immunomodulatory capacity of IDO has been best studied in the context of the adaptive immune response, where induction of this enzyme in dendritic cells restricts the proliferation and survival of T effector cells (1-4). This activity is driven by the breakdown of tryptophan, which both reduces the supply of this essential amino acid available to local T cells and generates an array of bioactive downstream metabolites collectively referred to as kynurenines (1,5,6).Recent studies have identified components of the cellular machinery involved in IDO-dependent responses in lymphocytes. IDO-mediated degradation of tryptophan promotes T cell apoptosis and suppresses proliferation, in part because tryptophan starvation activates the GCN2 pathway, which responds to amino acid insufficiency by initiating a stress response that results in general repression of translation (7,8). The details of how activation of this stress-response pathway alters the T cell activation program are not fully elucidated but likely involve translational regulation of cell cy...